These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 23835249)
1. Adverse effects of human immunoglobulin therapy. Stiehm ER Transfus Med Rev; 2013 Jul; 27(3):171-8. PubMed ID: 23835249 [TBL] [Abstract][Full Text] [Related]
2. Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence. Cherin P; Marie I; Michallet M; Pelus E; Dantal J; Crave JC; Delain JC; Viallard JF Autoimmun Rev; 2016 Jan; 15(1):71-81. PubMed ID: 26384525 [TBL] [Abstract][Full Text] [Related]
3. Adverse events associated with intravenous immunoglobulin therapy. Hamrock DJ Int Immunopharmacol; 2006 Apr; 6(4):535-42. PubMed ID: 16504916 [TBL] [Abstract][Full Text] [Related]
4. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466 [TBL] [Abstract][Full Text] [Related]
5. Preparation and use of therapeutic antibodies primarily of human origin. Stiehm ER; Keller MA; Vyas GN Biologicals; 2008 Nov; 36(6):363-74. PubMed ID: 18789721 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases. Stein MR; Koterba A; Rodden L; Berger M Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101 [TBL] [Abstract][Full Text] [Related]
7. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders. McCormack PL BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease. Wasserman RL; Irani AM; Tracy J; Tsoukas C; Stark D; Levy R; Chen J; Sorrells S; Roberts R; Gupta S Clin Exp Immunol; 2010 Sep; 161(3):518-26. PubMed ID: 20550549 [TBL] [Abstract][Full Text] [Related]
10. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Schiavotto C; Ruggeri M; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):35-40. PubMed ID: 8039756 [TBL] [Abstract][Full Text] [Related]
11. [The use of human immunoglobulins--adverse reactions]. Pituch-Noworolska A; Błaut-Szlósarczyk A; Zwonarz K Pol Merkur Lekarski; 2010 Sep; 29(171):202-5. PubMed ID: 20931833 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin Replacement Therapy for Primary Immunodeficiency. Sriaroon P; Ballow M Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315 [TBL] [Abstract][Full Text] [Related]